Casey Hoyt - Jan 17, 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role: Chief Executive Officer, Director
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol: VMD
Transactions as of: Jan 17, 2024
Transactions value $: -$280,283
Form type: 4
Date filed: 1/19/2024, 05:49 PM
Previous filing: Aug 16, 2023
Next filing: Jan 26, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VMD	Common Shares	Options Exercise		+10K	+7.12%		151K	Jan 17, 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	-$74K	-10K	-6.65%	$7.39	141K	Jan 17, 2024	Direct	F2
transaction	VMD	Common Shares	Options Exercise		+40.1K	+28.48%		181K	Jan 17, 2024	Direct	F3
transaction	VMD	Common Shares	Tax liability	-$98.7K	-13.4K	-7.39%	$7.39	167K	Jan 17, 2024	Direct	F2, F4
transaction	VMD	Common Shares	Options Exercise		+14.1K	+8.43%		181K	Jan 18, 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	-$108K	-14.1K	-7.78%	$7.62	167K	Jan 18, 2024	Direct	F5
holding	VMD	Common Shares						2.01M	Jan 17, 2024	by Elizabeth Rose Homes LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VMD	Phantom Share Units	Options Exercise		-10K	-33.33%		20K	Jan 17, 2024	Common Shares	10K		Direct	F1, F6
transaction	VMD	Restricted Stock Units	Options Exercise	$0	-40.1K	-33.33%	$0.00	80.1K	Jan 17, 2024	Common Shares	40.1K		Direct	F3, F7
transaction	VMD	Phantom Share Units	Options Exercise		-14.1K	-50%		14.1K	Jan 18, 2024	Common Shares	14.1K		Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2	Per share value is based on the market closing price of the common shares for January 17, 2024.
F3	Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F4	Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F5	Per share value is based on the market closing price of the common shares for January 18, 2024.
F6	Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7	Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F8	Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.